Literature DB >> 23733004

The efficiency of targeted intervention in limiting the spread of HIV and Hepatitis C Virus among injecting drug users.

Anneke S De Vos1, Mirjam E E Kretzschmar.   

Abstract

BACKGROUND: Interventions aimed at minimizing the spread of blood borne infections among Injecting Drug Users (IDU) are impeded by limitations in resources. To enhance their efficiency, it may be beneficial to target specific behavioural subpopulations, distinguished by syringe sharing tendencies.
METHODS: We used mathematical modelling to explore the effects of two types of intervention: removal of individuals from the injecting population and risk decrease at group-level (e.g. distribution of syringes). We computed the direct effects of intervention on the probability of obtaining and spreading infection as a function of baseline risk behaviour. Population level effects of (targeted) intervention were explored using a differential equations model, which incorporated two levels of risk.
RESULTS: Within most scenarios of risk distribution considered, HIV could be substantially reduced or eliminated by targeting high risk IDU only. Conversely, higher incidence reductions for HCV were reached in many scenarios when targeting low risk IDU. The potential for preventing infections by removal of uninfected IDU increases with baseline risk, but so does the probability that an IDU is already infected before being reached by intervention. Decreasing risk is likely to only delay rather than prevent infection for IDU borrowing many syringes, especially for a very infectious disease such as HCV.
CONCLUSIONS: The efficiency of intervention on injecting drug users may be much enhanced by targeting specific risk subgroups. However, the optimal targeting policy depends strongly on the infection under consideration. Crown
Copyright © 2013. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Epidemiology; Mathematical modelling; Risk variability

Mesh:

Year:  2013        PMID: 23733004     DOI: 10.1016/j.jtbi.2013.05.017

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  7 in total

Review 1.  Mathematical modeling of hepatitis c virus (HCV) prevention among people who inject drugs: A review of the literature and insights for elimination strategies.

Authors:  Ashley B Pitcher; Annick Borquez; Britt Skaathun; Natasha K Martin
Journal:  J Theor Biol       Date:  2018-11-16       Impact factor: 2.691

Review 2.  Modeling hepatitis C virus transmission among people who inject drugs: Assumptions, limitations and future challenges.

Authors:  Nick Scott; Margaret Hellard; Emma Sue McBryde
Journal:  Virulence       Date:  2015-08-25       Impact factor: 5.882

3.  HIV-1 and hepatitis C virus selection bottleneck in Chinese people who inject drugs.

Authors:  Fan Li; Liying Ma; Yi Feng; Yuhua Ruan; Jing Hu; Hongshuo Song; Pengtao Liu; Jun Ma; Baolin Rui; Kate Kerpen; Benjamin Scheinfeld; Tuhina Srivastava; David Metzger; Hui Li; Katharine J Bar; Yiming Shao
Journal:  AIDS       Date:  2018-01-28       Impact factor: 4.177

4.  Policy responses to viral hepatitis B and C among people who inject drugs in Member States of the WHO European region: a sub-analysis of the WHO 2013 global hepatitis policy survey.

Authors:  Alexander Spina; Irina Eramova; Jeffrey V Lazarus
Journal:  BMC Infect Dis       Date:  2014-09-19       Impact factor: 3.090

5.  Modeling a dynamic bi-layer contact network of injection drug users and the spread of blood-borne infections.

Authors:  Rui Fu; Alexander Gutfraind; Margaret L Brandeau
Journal:  Math Biosci       Date:  2016-01-14       Impact factor: 3.935

6.  Are Interferon-Free Direct-Acting Antivirals for the Treatment of HCV Enough to Control the Epidemic among People Who Inject Drugs?

Authors:  Viviane D Lima; Ignacio Rozada; Jason Grebely; Mark Hull; Lillian Lourenco; Bohdan Nosyk; Mel Krajden; Eric Yoshida; Evan Wood; Julio S G Montaner
Journal:  PLoS One       Date:  2015-12-03       Impact factor: 3.240

7.  Monitoring quality and coverage of harm reduction services for people who use drugs: a consensus study.

Authors:  Lucas Wiessing; Marica Ferri; Vendula Běláčková; Patrizia Carrieri; Samuel R Friedman; Cinta Folch; Kate Dolan; Brian Galvin; Peter Vickerman; Jeffrey V Lazarus; Viktor Mravčík; Mirjam Kretzschmar; Vana Sypsa; Ana Sarasa-Renedo; Anneli Uusküla; Dimitrios Paraskevis; Luis Mendão; Diana Rossi; Nadine van Gelder; Luke Mitcheson; Letizia Paoli; Cristina Diaz Gomez; Maitena Milhet; Nicoleta Dascalu; Jonathan Knight; Gordon Hay; Eleni Kalamara; Roland Simon; Catherine Comiskey; Carla Rossi; Paul Griffiths
Journal:  Harm Reduct J       Date:  2017-04-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.